References
- Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631–644.
- Dhariwal NK, Lynde GC. Update in the Management of Patients with Preeclampsia. Anesthesiol Clin. 2017;35(1):95–106.
- Pillay P, Moodley K, Moodley J, et al. Placenta-derived exosomes: potential biomarkers of preeclampsia. Int J Nanomedicine. 2017;12:8009–8023.
- Hansson SR, Naav A, Erlandsson L. Oxidative stress in preeclampsia and the role of free fetal hemoglobin. Front Physiol. 2014;5:516.
- Lu X. The Role of Exosomes and Exosome-derived microRNAs in Atherosclerosis. Curr Pharm Des. 2017;23(40):6182–6193.
- Alenquer M, Amorim MJ. Exosome Biogenesis, Regulation, and Function in Viral Infection. Viruses. 2015;7(9):5066–5083.
- Sun L, Li D, Song K, et al. Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro. Sci Rep. 2017;7(1):2552.
- Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24. .
- Tang L, Yin Y, Liu J, et al. MiR-124 Attenuates Osteoclastogenic Differentiation of Bone Marrow Monocytes Via Targeting Rab27a. Cell Physiol Biochem. 2017;43(4):1663–1672. .
- Hu TX, Guo X, Wang G, et al. MiR133b is involved in endogenous hydrogen sulfide suppression of sFlt-1 production in human placenta. Placenta. 2017;52:33–40.
- Wang X, Bu J, Liu X, et al. miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer. Oncotarget. 2017;8(38):63935–63948. .
- Zhen Y, Liu J, Huang Y, et al. miR-133b Inhibits Cell Growth, Migration, and Invasion by Targeting MMP9 in Non-Small Cell Lung Cancer. Oncol Res. 2017;25(7):1109–1116. .
- Kong C, Sun L, Zhang M, et al. miR-133b Reverses the Hydrosalpinx-induced Impairment of Embryo Attachment Through Down-regulation of SGK1. J Clin Endocrinol Metab. 2016;101(4):1478–1489. .
- Talarico C, Dattilo V, D’Antona L, et al. SGK1, the New Player in the Game of Resistance: chemo-Radio Molecular Target and Strategy for Inhibition. Cell Physiol Biochem. 2016;39(5):1863–1876. .
- Liang X, Lan C, Jiao G, et al. Therapeutic inhibition of SGK1 suppresses colorectal cancer. Exp Mol Med. 2017;49(11):e399. .
- Witcher PM. Preeclampsia: acute Complications and Management Priorities. AACN Adv Crit Care. 2018;29(3):316–326.
- Song X, Luo X, Gao Q, et al. Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia. Curr Drug Targets. 2017;18(10):1165–1170. .
- Skalis G, Katsi V, Miliou A, et al. MicroRNAs in Preeclampsia. MicroRNA. 2019;8(1):28–35. .
- Cheng Y, Jia B, Wang Y, et al. miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARgamma in gastric cancer. Oncol Rep. 2017;38(5):3220–3226. .
- Yang L, Hou J, Cui X-H, et al. MiR-133b regulates the expression of CTGF in epithelial-mesenchymal transition of ovarian cancer. Eur Rev Med Pharmacol Sci. 2017;21(24):5602–5609. .
- Matschke J, Wiebeck E, Hurst S, et al. Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia. Radiat Oncol. 2016;11:75.
- Liu W, Wang X, Liu Z, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway. Br J Cancer. 2017;117(8):1139–1153. .
- Li P, Hao Y, Pan F-H, et al. SGK1 inhibitor reverses hyperglycemia partly through decreasing glucose absorption. J Mol Endocrinol. 2016;56(4):301–309. .
- Wang QY, Zhou C-X, Zhan M-N, et al. MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer. Cell Death Dis. 2018;9(7):752. .
- Sugiyama T, Taniguchi K, Matsuhashi N, et al. MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1. Cancer Sci. 2016;107(12):1767–1775. .
- Cheng N, Wang GH. miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation. Exp Ther Med. 2016;11(4):1469–1474.
- Li D, Zhang P, Yao X, et al. Exosomes Derived From miR-133b-Modified Mesenchymal Stem Cells Promote Recovery After Spinal Cord Injury. Front Neurosci. 2018;12:845.
- Ren ZW, Zhou J-G, Xiong Z-K, et al. Effect of exosomes derived from MiR-133b-modified ADSCs on the recovery of neurological function after SCI. Eur Rev Med Pharmacol Sci. 2019;23(1):52–60. .
- Xin H, Li Y, Buller B, et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012;30(7):1556–1564.